IPP Bureau
Biosynthetic Technologies raises $7.5 million
By IPP Bureau - February 08, 2022
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
India grants Emergency Use Authorisation to Sputnik Light
By IPP Bureau - February 07, 2022
This is the ninth Covid-19 vaccine approved in India
Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct
By IPP Bureau - February 07, 2022
Key takeaways of recent quarter & conference call highlights
Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19
By IPP Bureau - February 07, 2022
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Venus Remedies join AMR alliance to combat global health threat
By IPP Bureau - February 07, 2022
The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
Rahul Guha to join Thyrocare Technologies as MD & CEO
By IPP Bureau - February 07, 2022
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice
WHO Goodwill Ambassador calls for renewed focus on leprosy
By IPP Bureau - February 07, 2022
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
By IPP Bureau - February 07, 2022
Takes charge to lead business innovation, strategy, alliance & partnerships
Serum receives green light for Omicron variant vaccine
By IPP Bureau - February 07, 2022
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
By IPP Bureau - February 05, 2022
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore
By IPP Bureau - February 05, 2022
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore
By IPP Bureau - February 05, 2022
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis Q3FY22 PAT at Rs. 35.38 crore
By IPP Bureau - February 05, 2022
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Sanofi unveils new corporate brand and logo
By IPP Bureau - February 05, 2022
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
Expert panel recommends Emergency Use Authorisation for Sputnik Light
By IPP Bureau - February 05, 2022
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
